0001104659-16-131001.txt : 20160705
0001104659-16-131001.hdr.sgml : 20160705
20160705161544
ACCESSION NUMBER: 0001104659-16-131001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160630
FILED AS OF DATE: 20160705
DATE AS OF CHANGE: 20160705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dhanda Rahul
CENTRAL INDEX KEY: 0001667658
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 161750642
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
a4.xml
4
X0306
4
2016-06-30
0
0001492674
T2 Biosystems, Inc.
TTOO
0001667658
Dhanda Rahul
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
SVP of Corporate Development
Common Stock
2016-06-30
4
M
0
3589
2.45
A
3589
D
Common Stock
2016-06-30
4
S
0
3589
8.16
D
0
D
Stock Option (Right to Buy)
2.45
2016-06-30
4
M
0
3589
0
D
2016-01-17
2022-01-17
Common Stock
3589
31705
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016.
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.15 to $8.24. The reporting person undertakes to provide upon request the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Michael Gibbs Attorney-in-fact
2016-07-05